Trial
NCT01425216
Sorafenib for Patients With Extensive Keloids
Phase IITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Tirgan, Michael H., M.D.
Collaborators
—
Condition
Keloids
Intervention
Sorafenib
Why stopped
IND application was not approved by the US FDA - Project was never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-18